Contacts between Extracellular Loop Two and Transmembrane Helix Six Determine Basal Activity of the Thyroid-stimulating Hormone Receptor

Abstract

A number of alanine mutations in extracellular loop two (ECL2) of the thyroid-stimulating hormone receptor (TSHR) were found to increase or decrease basal activity when compared with the wild type receptor. K565A was identified as a mutant with decreased basal activity, and strongly impaired hormone induced signaling activity. To gain insights into how ECL2 mutants affect basal activity, we focused on constitutively activating pathogenic mutant I568V in ECL2, which exhibits elevated basal activity. Because our molecular model suggests that Ile-568 is embedded in an environment of hydrophobic residues provided by transmembrane helix bundle, we tested mutants in this region to identify potential interaction partner(s) the mutant the basal activity by I568V a and ECL2 and in which interaction Ile-568 and the receptor in a with basal activity. the mutant exhibits basal activity wild and the in wild type basal activity to the is by the mutant of activity of and decreased activity of mutant basal activity of wild type and mutant a and of this signaling by of mutations in increase or decrease basal activity. A number of alanine mutations in extracellular loop two (ECL2) of the thyroid-stimulating hormone receptor (TSHR) were found to increase or decrease basal activity when compared with the wild type receptor. K565A was identified as a mutant with decreased basal activity, and strongly impaired hormone induced signaling activity. To gain insights into how ECL2 mutants affect basal activity, we focused on constitutively activating pathogenic mutant I568V in ECL2, which exhibits elevated basal activity. Because our molecular model suggests that Ile-568 is embedded in an environment of hydrophobic residues provided by transmembrane helix bundle, we tested mutants in this region to identify potential interaction partner(s) the mutant the basal activity by I568V a and ECL2 and in which interaction Ile-568 and the receptor in a with basal activity. the mutant exhibits basal activity wild and the in wild type basal activity to the is by the mutant of activity of and decreased activity of mutant basal activity of wild type and mutant a and of this signaling by of mutations in increase or decrease basal activity. hormone hormone hormone thyroid-stimulating transmembrane transmembrane extracellular extracellular constitutively activating wild hormone hormone thyroid-stimulating transmembrane transmembrane extracellular extracellular constitutively activating wild and a of the of the by and the of and the the of is a which is of the and is by mutants hormone activity and of in the or the the we a of of the ECL2 of to gain insights into how ECL2 the signaling pathogenic in the of hydrophobic ECL2, of hydrophobic by mutations in receptor Because in ECL2 pathogenic we a hydrophobic interaction Ile-568 in the wild type basal A model of the of on the the ECL2 the Ile-568 is the of ECL2 and is embedded in an environment of hydrophobic residues provided by and To identify hydrophobic residues the that with Ile-568 to the basal we tested and that a interaction with Ile-568 by the receptor the mutant signaling of I568V to wild type a and ECL2 and insights into in and the of ECL2 and basal activity of mutants were by the as as were with and were to the in the were by with and of were in with and in a were in or with of of the receptor was on a were the with and in and into were with and and with a of a in the were and with a of were and with was by the was and receptor of the mutants was to of to which was of were and in were with in a were with were by of the were with and by the of were and of the was the to the of were with were with by was in the were by as as the of the of in and of as a of activity is as basal as a of receptor by were in with of or mutant and were in the of of with were with were with and were and were the to the as a of receptor was to the of of molecular of ECL2 and the transmembrane were as in on of two receptor the two of ECL2 of and ECL2 residues were by alanine and hydrophobic were with type and were in basal and and with a the were as of alanine mutants ECL2 were with the receptor or mutant were as Because of the basal activity of the as to basal in and was with receptor was on a as of two in was as a to of in a and of ECL2 in this the and the that of the the the mutant of is as an pathogenic mutant by of the receptor is to the of and number that the mutants a in the of of with of mutants and of that the of the mutant is strongly to number of the this mutant was in and mutants of Ile-568 by basal signaling when compared with mutants and decreased basal basal signaling was signaling is with wild type or decreased mutants when compared with of mutant K565A with strongly impaired signaling of mutants were with that of the is by alanine mutants of and and by that in to the pathogenic mutants we a hydrophobic interaction Ile-568 with to the basal Ile-568 to a of we that the or when compared with in of the molecular model of the suggests that ECL2 is into the transmembrane on the extracellular is the of ECL2 and is by the which is to and embedded hydrophobic residues of and of Ile-568 in a hydrophobic the and and potential interaction and we tested potential hydrophobic interaction Ile-568 or alanine mutants the mutant in with was a activity of to and mutant a decreased basal activity activity we to this mutant the I568V in ECL2 and in in the mutant in of the of basal signaling of the mutant hormone was with I568V the decreased of the was with the mutant of the of Ile-568 ECL2 and potential interaction in the transmembrane model of on suggests a of Ile-568 the of ECL2 embedded in a hydrophobic environment by the residues and of mutants and hydrophobic interaction were by or alanine the potential interaction in and were with or mutant in and was with as of two in was as a to of in a of and ECL2 and in and was with as of two in was as a to of in a we tested the mutants and the mutant I568V and mutants mutant is to the of of and mutant with decreased basal activity in mutant the basal activity of wild of mutants I568V and basal activity mutants and is to and the signaling induced by is of wild the of ECL2 receptor signaling ECL2 of the to in hormone and to in the the to the the ECL2 of by to insights into the and the of and in ECL2 a in the of the alanine of ECL2 K565A to the impaired mutant with to basal and activity two that the activity of of in the the to is by of of or of is the of the receptor by to a interaction mutant is to the receptor K565A ECL2 is and an impaired mutants and of the a mutant K565A ECL2 to and a in the receptor the two and two the extracellular of is with and identified mutants in ECL2 that by impaired basal signaling activity to our ECL2, mutants with decreased basal activity with with the receptor the and and in the transmembrane is that of the mutants decreased basal decreased activity is in the as on we the that the activity of basal signaling to the to signaling of the and we that the of the basal activity is a and model on the of suggests a of ECL2 the extracellular into the transmembrane and of ECL2 by mutations hydrophobic Ile-568 in ECL2 is to the constitutively by mutations to and as pathogenic our Ile-568 is into a the transmembrane To identify hydrophobic residues in the that with Ile-568 as we potential interaction of Ile-568 with or and mutant is to of which to the and number in and is a on our we that in the a hydrophobic interaction and Ile-568 (ECL2) is to ECL2 in the basal of the and ECL2 by or by I568V as the ECL2 to a of this in receptor by of of a decreased basal activity with mutant by our model as to by an the of the of a a interaction with Ile-568 in in an when compared with the and and is to a the of the basal in the mutant the of is the of an interaction the two which is by model of and mutant ECL2 and in the the hydrophobic interaction and Ile-568 (ECL2) is to ECL2 into the basal of by mutants I568V ECL2 or by as the in to a of the interaction and to a receptor by of the to by an the of the a a interaction Ile-568 in an when compared with the of and and is to a the of the basal the mutant in ECL2 the as in the mutant the of is the of an interaction the two which is by the mutant an our we the mutants and the mutant that in the of and an by the of on the of by mutant on that a the ECL2 by mutant in a decreased basal activity the mutant the wild type basal activity I568V and mutants the mutant ECL2 is and to mutant the of with the decreased basal mutant in the mutant our by the basal activity of wild type as mutant is with our model and the in and the is by the of that our tested of ECL2 and the and of ECL2 to A is an of the as a the and the we identified on the of ECL2 as in the of a a a is that ECL2 ECL2 is into the transmembrane and is and of a a is a of an induced of ECL2 to the interaction and ECL2 in the basal a of ECL2 and the of the and the activity of the is that a of in is an of the as a mutants a is ECL2 in a of receptor in the the basal is by mutants with or by a ECL2 we identified ECL2 as in a a is ECL2 an induced the of ECL2 to the interaction and ECL2 and the of the hydrophobic interaction of and Ile-568 (ECL2) is the basal of wild type in this activity is to the the decreased basal activity is by a by with which a of in the to the and interaction and mutants a ECL2 to receptor basal activity is by interaction decreased basal activity is by a of in of mutant with which a of in the when compared with the by the and mutants in and when compared with the is the of the and with is by an and in the the is by mutants with of the or by ECL2 of which the we identified ECL2 and of which and we an the and ECL2, in which ECL2 to the receptor that ECL2 and and signaling to the to the and and hormone hormone hormone thyroid-stimulating transmembrane transmembrane extracellular extracellular constitutively activating wild hormone hormone thyroid-stimulating transmembrane transmembrane extracellular extracellular constitutively activating wild and a of the of the by and the of and the the of is a which is of the and is by mutants hormone activity and of in the or the the we a of of the ECL2 of to gain insights into how ECL2 the signaling activity. pathogenic in the of hydrophobic ECL2, of hydrophobic by mutations in receptor Because in ECL2 pathogenic we a hydrophobic interaction Ile-568 in the wild type basal A model of the of on the the ECL2 the Ile-568 is the of ECL2 and is embedded in an environment of hydrophobic residues provided by and To identify hydrophobic residues the that with Ile-568 to the basal we tested and that a interaction with Ile-568 by the receptor the mutant signaling of I568V to wild type a and ECL2 and insights into in and the of ECL2 and basal activity of mutants were by the as as were with and were to the in the were by with and of were in with and in a were in or with of of the receptor was on a were the with and in and into were with and and with a of a in the were and with a of were and with was by the was and receptor of the mutants was to of to which was of were and in were with in a were with were by of the were with and by the of were and of the was the to the of were with were with by was in the were by as as the of the of in and of as a of activity is as basal as a of receptor by were in with of or mutant and were in the of of with were with were with and were and were the to the as a of receptor was to the of of molecular of ECL2 and the transmembrane were as in on of two receptor the two of ECL2 of mutants were by the as as were with and were to the in the were by with and of were in with and in a were in or with of of the receptor was on a were the with and in and into were with and and with a of a in the were and with a of were and with was by the was and receptor of the mutants was to of to which was of were and in were with in a were with were by of the were with and by the of were and of the was the to the of were with were with by was in the were by as as the of the of in and of as a of activity is as basal as a of receptor by were in with of or mutant and were in the of of with were with were with and were and were the to the as a of receptor was to the of of molecular of ECL2 and the transmembrane were as in on of two receptor the two of ECL2 of and ECL2 residues were by alanine and hydrophobic were with type and were in basal and and with a the were as of alanine mutants ECL2 were with the receptor or mutant were as Because of the basal activity of the as to basal in and was with receptor was on a as of two in was as a to of in a and of ECL2 in this the and the that of the the the mutant of is as an pathogenic mutant by of the receptor is to the of and number that the mutants a in the of of with of mutants and of that the of the mutant is strongly to number of the this mutant was in and mutants of Ile-568 by basal signaling when compared with mutants and decreased basal basal signaling was signaling is with wild type or decreased mutants when compared with of mutant K565A with strongly impaired signaling of mutants were with that of the is by alanine mutants of and and by that in to the pathogenic mutants we a hydrophobic interaction Ile-568 with to the basal Ile-568 to a of we that the or when compared with in of the molecular model of the suggests that ECL2 is into the transmembrane on the extracellular is the of ECL2 and is by the which is to and embedded hydrophobic residues of and of Ile-568 in a hydrophobic the and and potential interaction and we tested potential hydrophobic interaction Ile-568 or alanine mutants the mutant in with was a activity of to and mutant a decreased basal activity activity we to this mutant the I568V in ECL2 and in in the mutant in of the of basal signaling of the mutant hormone was with I568V the decreased of the was with the mutant of mutants and hydrophobic interaction were by or alanine the potential interaction in and were with or mutant in and was with as of two in was as a to of in a of and ECL2 and in and was with as of two in was as a to of in a we tested the mutants and the mutant I568V and mutants mutant is to the of of and mutant with decreased basal activity in mutant the basal activity of wild of mutants I568V and basal activity mutants and is to and the signaling induced by is of wild and ECL2 residues were by alanine and hydrophobic were with type and were in basal and and with a the were as of alanine mutants ECL2 were with the receptor or mutant were as Because of the basal activity of the as to basal in and was with receptor was on a as of two in was as a to of in a and of ECL2 in this the and the that of the the the mutant of is as an pathogenic mutant by of the receptor is to the of and number that the mutants a in the of of with of mutants and of that the of the mutant is strongly to number of the this mutant was in and mutants of Ile-568 by basal signaling when compared with mutants and decreased basal basal signaling was signaling is with wild type or decreased mutants when compared with of mutant K565A with strongly impaired signaling of mutants were with that of the is by alanine mutants of and and by ECL2 residues were by alanine and hydrophobic were with type and were in basal and and with a the were as and of ECL2 in this the and the that of the the the mutant of is as an pathogenic mutant by of the receptor is to the of and number that the mutants a in the of of with of mutants and of that the of the mutant is strongly to number of the this mutant was in and mutants of Ile-568 by basal signaling when compared with mutants and decreased basal basal signaling was signaling is with wild type or decreased mutants when compared with of mutant K565A with strongly impaired signaling activity. of mutants were with that of the is by alanine mutants of and and by that in to the pathogenic mutants we a hydrophobic interaction Ile-568 with to the basal Ile-568 to a of we that the or when compared with in of the molecular model of the suggests that ECL2 is into the transmembrane on the extracellular is the of ECL2 and is by the which is to and embedded hydrophobic residues of and of Ile-568 in a hydrophobic the and and potential interaction and we tested potential hydrophobic interaction Ile-568 or alanine mutants the mutant in with was a activity of to and mutant a decreased basal activity activity we to this mutant the I568V in ECL2 and in in the mutant in of the of basal signaling of the mutant hormone was with I568V the decreased of the was with the mutant of mutants and hydrophobic interaction were by or alanine the potential interaction in and were with or mutant in and was with as of two in was as a to of in a of and ECL2 and in and was with as of two in was as a to of in a we tested the mutants and the mutant I568V and mutants mutant is to the of of and mutant with decreased basal activity in mutant the basal activity of wild of mutants I568V and basal activity mutants and is to and the signaling induced by is of wild that in to the pathogenic mutants we a hydrophobic interaction Ile-568 with to the basal Ile-568 to a of we that the or when compared with in of the molecular model of the suggests that ECL2 is into the transmembrane on the extracellular is the of ECL2 and is by the which is to and embedded hydrophobic residues of and of Ile-568 in a hydrophobic the and and potential interaction and we tested potential hydrophobic interaction Ile-568 or alanine mutants the mutant in with was a activity of to and mutant a decreased basal activity activity we to this mutant the I568V in ECL2 and in in the mutant in of the of basal signaling of the mutant hormone was with I568V the decreased of the was with the mutant we tested the mutants and the mutant I568V and mutants mutant is to the of of and mutant with decreased basal activity in mutant the basal activity of wild of mutants I568V and basal activity mutants and is to and the signaling induced by is of wild the of ECL2 receptor signaling ECL2 of the to in hormone and to in the the to the the ECL2 of by to insights into the and the of and in ECL2 a in the of the alanine of ECL2 K565A to the impaired mutant with to basal and activity two that the activity of of in the the to is by of of or of is the of the receptor by to a interaction mutant is to the receptor K565A ECL2 is and an impaired mutants and of the a mutant K565A ECL2 to and a in the receptor the two and two the extracellular of is with and identified mutants in ECL2 that by impaired basal signaling activity to our ECL2, mutants with decreased basal activity with with the receptor the and and in the transmembrane is that of the mutants decreased basal decreased activity is in the as on we the that the activity of basal signaling to the to signaling of the and we that the of the basal activity is a and model on the of suggests a of ECL2 the extracellular into the transmembrane and of ECL2 by mutations hydrophobic Ile-568 in ECL2 is to the constitutively by mutations to and as pathogenic our Ile-568 is into a the transmembrane To identify hydrophobic residues in the that with Ile-568 as we potential interaction of Ile-568 with or and mutant is to of which to the and number in and is a on our we that in the a hydrophobic interaction and Ile-568 (ECL2) is to ECL2 in the basal of the and ECL2 by or by I568V as the ECL2 to a of this in receptor by of of a decreased basal activity with mutant by our model as to by an the of the of a a interaction with Ile-568 in in an when compared with the and and is to a the of the basal in the mutant the of is the of an interaction the two which is by our we the mutants and the mutant that in the of and an by the of on the of by mutant on that a the ECL2 by mutant in a decreased basal activity the mutant the wild type basal activity I568V and mutants the mutant ECL2 is and to mutant the of with the decreased basal mutant in the mutant our by the basal activity of wild type as mutant is with our model and the in and the is by the of that our tested of ECL2 and the and of ECL2 to A is an of the as a the and the we identified on the of ECL2 as in the of a a a is that ECL2 ECL2 is into the transmembrane and is and of a a is a of an induced of ECL2 to the interaction and ECL2 in the basal a of ECL2 and the of the and the activity of the is that a of in is an of the as a mutants a is ECL2 in a of receptor in the the basal is by mutants with or by a ECL2 we identified ECL2 as in a a is ECL2 an induced the of ECL2 to the interaction and ECL2 and the of the hydrophobic interaction of and Ile-568 (ECL2) is the basal of wild type in this activity is to the the decreased basal activity is by a by with which a of in the to the and interaction and mutants a ECL2 to receptor basal activity is by interaction decreased basal activity is by a of in of mutant with which a of in the when compared with the by the and mutants in and when compared with the is the of the and with is by an and in the the is by mutants with of the or by ECL2 of which the we identified ECL2 and of which and we an the and ECL2, in which ECL2 to the receptor that ECL2 and and signaling to the to the and and the of ECL2 receptor signaling ECL2 of the to in hormone and to in the the to the the ECL2 of by to insights into the and the of and in ECL2 a in the of the alanine of ECL2 K565A to the impaired mutant with to basal and activity two that the activity of of in the the to is by of of or of is the of the receptor by to a interaction mutant is to the receptor K565A ECL2 is and an impaired mutants and of the a mutant K565A ECL2 to and a in the receptor the two and two the extracellular of is with and identified mutants in ECL2 that by impaired basal signaling activity to our ECL2, mutants with decreased basal activity with with the receptor the and and in the transmembrane is that of the mutants decreased basal decreased activity is in the as on we the that the activity of basal signaling to the to signaling of the and we that the of the basal activity is a and model on the of suggests a of ECL2 the extracellular into the transmembrane and of ECL2 by mutations hydrophobic Ile-568 in ECL2 is to the constitutively by mutations to and as pathogenic our Ile-568 is into a the transmembrane To identify hydrophobic residues in the that with Ile-568 as we potential interaction of Ile-568 with or and mutant is to of which to the and number in and is a on our we that in the a hydrophobic interaction and Ile-568 (ECL2) is to ECL2 in the basal of the and ECL2 by or by I568V as the ECL2 to a of this in receptor by of of a decreased basal activity with mutant by our model as to by an the of the of a a interaction with Ile-568 in in an when compared with the and and is to a the of the basal in the mutant the of is the of an interaction the two which is by To our we the mutants and the mutant that in the of and an by the of on the of by mutant on that a the ECL2 by mutant in a decreased basal activity the mutant the wild type basal activity I568V and mutants the mutant ECL2 is and to mutant the of with the decreased basal mutant in the mutant our by the basal activity of wild type as mutant is with our model and the in and the is by the of that our tested of ECL2 and the and of ECL2 to A is an of the as a the and the we identified on the of ECL2 as in the of a a a is that ECL2 ECL2 is into the transmembrane and is and of a a is a of an induced of ECL2 to the interaction and ECL2 in the basal a of ECL2 and the of mutants a ECL2 to receptor basal activity is by interaction decreased basal activity is by a of in of mutant with which a of in the when compared with the by the and mutants in and when compared with the is the of the and with is by an and in the the is by mutants with of the or by ECL2 of which the we identified ECL2 and of which and we an the and ECL2, in which ECL2 to the receptor that ECL2 and and signaling to the to the and and of the and with with